SCHEMBL6640374

SCHEMBL6640374

N#Cc1ccc(OCc2nc3cc([N+](=O)[O-])ccc3[nH]2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNJ1 P48048 2/20 0.53
SMN1; SMN2 Q16637 6/20 0.49
LMNA P02545 4/20 0.49
MAPT P10636 3/20 0.49
ALDH1A1 P00352 3/20 0.49
KMT2A Q03164 3/20 0.49
MEN1 O00255 2/20 0.49
GAA P10253 2/20 0.49
HTT P42858 2/20 0.49
NPC1 O15118 7/20 0.48
PKM P14618 3/20 0.48
CYP19A1 P11511 2/20 0.45
GRIN1 Q05586 1/20 0.44
GRIN2B Q13224 1/20 0.44
KDM4E B2RXH2 1/20 0.44
RAB9A P51151 6/20 0.43
TP53 P04637 2/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31686984 0.86 RAB9A (0.60) KCNJ1SMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL8027000 0.84 RIPK1 (0.58) KCNJ1SMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL14726056 0.80 KCNJ1 (0.79) KCNJ1LMNAMAPTALDH1A1KMT2A
SCHEMBL7394379 0.80 SMN1; SMN2 (0.48) SMN1; SMN2LMNAMAPTALDH1A1KMT2A
SCHEMBL3147838 0.79 CHEK2 (0.53) KCNJ1SMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL25437311 0.78 NPC1 (0.68) KCNJ1SMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL30354827 0.78 NPC1 (0.68) KCNJ1SMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL3304619 0.78 KCNJ1 (0.63) KCNJ1SMN1; SMN2LMNAMAPTALDH1A1
SCHEMBL3388853 0.78 MAPT (0.53) KCNJ1LMNAMAPTALDH1A1KMT2A
SCHEMBL9281837 0.77 NPC1 (0.61) SMN1; SMN2LMNAMAPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 EP disclosed
EP-1100795-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM ZENTRALE GMBH (DE) 2001-05-23 EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 US disclosed
WO-2000008014-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-02-17 WO disclosed